Aytu BioPharma, Inc. (NasdaqCM: AYTU)
Health Care · Pharmaceuticals · US
$2.02
-0.25% today · -13.5% 1Y
Aytu BioPharma, Inc. (NasdaqCM: AYTU) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $22.01M and employs 76 people.
Over the last twelve months the share price has lost 13.5%, trading between 1.80 and 3.07.
Tweenvest scores Aytu BioPharma, Inc. across four factors: quality 52/100, value 53/100, growth 0/100. Its strongest factor is value.
AYTU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.01M
- Revenue (TTM)
- $57.57M
- P/E
- —
- EPS
- -1.16
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- $3.07
- 52-week low
- $1.80
- Avg volume (3M)
- —
- Shares outstanding
- 10.87M
- Employees
- 76
- Next earnings
- —
About Aytu BioPharma, Inc.
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailored for individuals between 6 and 17 years old; and Adzenys ER, an oral liquid formulation also for those 6 years and older. Additionally, the company offers Karbinal ER, an oral carbinoxamine suspension for managing seasonal and perennial allergies. It also provides Poly-Vi-Flor and Tri-Vi-Flor, which are prescription vitamin supplements designed for infants and children with fluoride deficiencies. Other products include Tuzistra XR, a prescription cough suppressant oral suspension containing codeine polistirex and chlorpheniramine polistirex, and ZolpiMist, an oral spray indicated for addressing insomnia. Founded in 2015, the company was previously known as Aytu BioScience, Inc. before officially changing its name to Aytu BioPharma, Inc. in March 2021. Its corporate headquarters are located in Englewood, Colorado.
- ISIN
- US0547548588
- Listed since
- Sep 25, 2008
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Optimi Health Corp.CNSX: OPTI | $22.87M | CA$5.70 | -10.94% |
| Provectus Biopharmaceuticals, Inc.OTCPK: PVCT | $22.23M | $0.05 | -2.76% |
| Sat Kartar Life LimitedNSEI: SATKARTAR | $22.22M | Rs136.60 | -25.80% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
Figures last refreshed Oct 11, 2026.